Eton Pharmaceuticals relaunches HEMANGEOL® Oral Solution with Eton Cares and Exclusive Specialty Pharmacy Distribution
Eton Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, March 19, 2026
Eton Pharmaceuticals Expands Rare Disease Portfolio Through Acquisition of U.S. Commercialization Rights to HEMANGEOL® Oral Solution
Eton Pharmaceuticals to Participate at Leerink Partners Global Healthcare Conference on Wednesday, March 11th
Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th
Providence Gold Reports Up to 8.0 g/t Au from Mojave Girl Stockpile Sampling; Phase 2 Evaluation at Tarantula Site To Begin
Silver Hammer Commences Summer Exploration Program at Its Strategically Located Fahey Silver Project in the Silver Valley of Idaho
